Zandu Realty Ltd. - (Amalgamated) - Stock Valuation and Financial Performance

BSE: 506720 | NSE: ZANDUREALT | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Zandu Realty-(Amalga

M-Cap below 100cr DeciZen not available

Zandu Realty Ltd. - (Amalgamated) stock performance -

mw4me loader
P/E Ratio (SA):
24.21
Market Cap:
152.9 Cr.
52-wk low:
1,850
52-wk high:
1,950.9

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

The key valuation ratios of Zandu Realty Ltd. - (Amalgamated)'s currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is a good buy now?

No data found

10 Year X-Ray of Zandu Realty-(Amalga:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17TTM
ROCE % 22%27.7%5.6%0.6%-29.9%0.7%18.7%29.6%4.1%3.1%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 13687.3007002986.98.75.10
Sales YoY Gr.--35.9%-100%NANA-100%NA199.3%-90%-40.8%-
Adj EPS 196.417116.411.3-871.616.7476.6797.187.464.278.3
YoY Gr.--12.9%-90.4%-30.6%-7785.6%NA2750.4%67.2%-89%-26.5%-
BVPS (₹) 962.9285.4302.6314887903.71,380.32,177.32,264.82,3292,303.5
Adj Net
Profit
15.813.81.30.9-70.31.438.464.37.15.26
Cash Flow from Ops. 22.813.50-1.472.2-565.67-36-
Debt/CF from Ops. 0000000501.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -30.5%-40.7%-43.9%-40.8%
Adj EPS -11.7%NA-48.7%-26.5%
BVPS10.3%21.3%19.1%2.8%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17TTM
Return on
Equity %
21.727.45.60.6-29.90.718.631.43.62.63.4
Op. Profit
Mgn %
17.120.800-102.1077.3-3.5-39.2-72.6-1607.6
Net Profit
Mgn %
11.615.800-100.40132.37481.31016312.6
Debt to
Equity
00000000.200.1-
Working Cap
Days
8673001,25501,5744923,1822,9989,338
Cash Conv.
Cycle
940094101,3692818929698,685

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Net Profit has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Zandu Realty Ltd. - (Amalgamated)

Standalone Consolidated
TTM EPS (₹) 78.3 156.6
TTM Sales (₹ Cr.) 0.1 104
BVPS (₹.) 2,303.5 285.4
Reserves (₹ Cr.) 178 15
P/BV 0.82 6.64
PE 24.21 12.10
From the Market
52 Week Low / High (₹) 1850.00 / 1950.90
All Time Low / High (₹) 650.00 / 24643.20
Market Cap (₹ Cr.) 153
Equity (₹ Cr.) 8.1
Face Value (₹) 100
Industry PE 47.5

Management X-Ray of Zandu Realty-(Amalga:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Zandu Realty-(Amalga

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17
Sales136.2487.290070029.0486.918.675.13
Operating Expenses 113.0970.330.840.64141.433.576.5989.9312.078.85
Manufacturing Costs26.4517.300.140.080.010.020.190.140.040.04
Material Costs37.2021.2000139.412.564.7882.567.554.23
Employee Cost 13.658.56000000.050.300.31
Other Costs 35.7723.270.710.552.020.991.627.184.174.28
Operating Profit 23.1516.96-0.84-0.64-71.43-3.5722.45-3.02-3.40-3.72
Operating Profit Margin (%) 17.0%19.4%---102.0%-77.3%-3.5%-39.2%-72.6%
Other Income 4.175.842.161.454.615.6827.4486.7614.5411.68
Interest 0.400.2400000.342.162.321.42
Depreciation 2.621.4500000000
Exceptional Items 0000000000
Profit Before Tax 24.3121.111.320.81-66.822.1249.5581.588.826.54
Tax 7.905.86-0.07-0.103.460.7711.1217.301.771.36
Profit After Tax 16.4115.251.390.91-70.281.3538.4364.277.055.18
PAT Margin (%) 12.0%17.5%---100.0%-132.3%74.0%81.3%101.0%
Adjusted EPS (₹)203.5189.217.311.3-871.016.7476.6797.187.464.2
Dividend Payout Ratio (%)37%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17

Equity and Liabilities

Shareholders Fund 77.6523.0124.40270.30200.01201.36213.05196.75196.43197.49
Share Capital 8.068.068.068.068.068.068.068.068.068.06
Reserves 69.5814.9516.34262.23191.95193.30204.99188.69188.37189.42
Minority Interest0000000000
Debt0.1600000035011.40
Long Term Debt0.16000000000
Short Term Debt000000035011.40
Trade Payables11.280.010.640.03000000
Others Liabilities 16.121.0517.099.803.740.7156.030.591.020.44
Total Liabilities 105.2024.0742.13280.13203.76202.07269.09232.34197.46209.33

Fixed Assets

Gross Block68.720.266.260000000
Accumulated Depreciation50.720.240.240000000
Net Fixed Assets180.026.020000000
CWIP 26.19000000000
Investments 12.0322.491.460.010.0191.51125.21135.21140.09182.37
Inventories16.0500251111.59109.03104.2521.6914.149.92
Trade Receivables3.36000004.573.363.150
Cash Equivalents 12.540.651.102.010.670.563.443.360.040.06
Others Assets17.030.9233.5627.1191.480.9731.6268.7340.0416.98
Total Assets 105.2024.0742.13280.13203.76202.07269.09232.34197.46209.33

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17
Cash Flow From Operating Activity 22.8313.520.04-1.3672.22-5.0165.627.01-3.025.95
PBT 24.3121.111.320.81-66.822.1249.5581.588.826.54
Adjustment -0.583.08-1.87-1.45-4.56-5.36-26.53-84.88-12.50-9.92
Changes in Working Capital 6.74-2.770.63-1.67144.62.3543.5439.532.4310.69
Tax Paid -7.65-7.90-0.040.95-1-4.11-0.94-29.22-1.77-1.36
Cash Flow From Investing Activity -16.76-17.540.292.28-73.564.89-62.72-39.9836.60-15.98
Capex -10.03-8.33-60000000
Net Investments -4.92-8.4521.141.450-91.50-33.70-10-4.88-42.28
Others -1.80-0.76-14.850.83-73.5696.39-29.02-29.9841.4826.30
Cash Flow From Financing Activity -5.94-2.290.12000-0.0132.88-36.9010.06
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 000000-0.01-2.12-1.90-1.34
Dividend Paid -5-1.930.120000000
Others -0.94-0.360000035-3511.40
Net Cash Flow 0.13-6.320.450.92-1.34-0.122.89-0.09-3.320.03
PARTICULARSMar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17
Ratios
ROE (%)22.4630.315.873.68-145.141.8741.7344.813.942.8
ROCE (%)33.7442.355.563.27-1382.9354.1852.035.674.17
Asset Turnover Ratio1.571.45000.2900.120.350.040.03
PAT to CFO Conversion(x)1.390.890.03-1.49N/A-3.711.710.11-0.431.15
Working Capital Days
Receivable Days80000057171370
Inventory Days4100094501,340264755856
Payable Days1099700000000

Zandu Realty Ltd. - (Amalgamated) Stock News

Zandu Realty Ltd. - (Amalgamated) FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Zandu Realty-(Amalga on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Zandu Realty-(Amalga stood at ₹152.9.
The latest P/E ratio of Zandu Realty-(Amalga as of 01-Jan-1970 05:30 is 24.21.
The latest P/B ratio of Zandu Realty-(Amalga as of 01-Jan-1970 05:30 is 0.82.
The 52-week high of Zandu Realty-(Amalga is ₹1,950.9 and the 52-week low is ₹1,850.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zandu Realty-(Amalga is ₹0.10 ( Cr.) .

About Zandu Realty Ltd. - (Amalgamated)

Zandu Pharmaceutical works name was changed to Zandu Realty from March 10, 2010. At present, the company is a multi-product entity, comprising a group of companies. Zandu projects a sale of nearly Rs. 2,000/- Million by 2000 A.D.

It was listed in 1919; is engaged in offering ayurvedic healthcare medicines.

Zandu manufactures a wide range of ayurvedic medicine specialised in area of rheumatology, gynaecology and CNS (Central nervous system).

Using 200 medicinal plants and their extracts it manufactures 300 healthcare products. The company markets its products under the brand name Zandu.

The company exports herbal health care products to U.S.A, Europe and Asian countries.

The chemical division is located at Ankleshwar that manufactures bulk drugs and intermediates. The cosmetics division manufactures wide range of skin care products such as lotion, soaps, shampoo, creams, etc. It markets the cosmetic products under name Z-naree.

It manufactures products such as zandu balm, brento, kesari-jivan, zandu honey, triphala churna, sudarshan, rhumasyl oil, gulbahar, chandra prabhavati, etc.

ZPWL has formed joint venture with Gujarat Agro Industries Corporation to manufacture glycyrrhiza extract from a vegetable plant-extraction project.

In the year 1989 Leopard Investments Private Limited has become the subsidiary of ZPWL.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.